WHWK Stock Summary and Trading Ideas (Whitehawk Therapeutics | NASDAQ:WHWK)

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Whitehawk Therapeutics trades on the NASDAQ stock market under the symbol WHWK.

As of April 24, 2026, WHWK stock price declined to $4.02 with 24,679 million shares trading.

WHWK has a beta of 1.37, meaning it tends to be more sensitive to market movements. WHWK has a correlation of 0.11 to the broad based SPY ETF.

WHWK has a market cap of $189.73 million. This is considered a Micro Cap stock.

Last quarter Whitehawk Therapeutics reported $0 in Revenue and -$.34 earnings per share. This fell short of revenue expectation by $-20 million and exceeded earnings estimates by $.04.

The top ETF exchange traded funds that WHWK belongs to (by Net Assets): VTI, VXF, IWC, AVSC, AVTM.

WHWK has outperformed the market in the last year with a price return of +161.0% while the SPY ETF gained +34.4%. WHWK has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +48.9% and +13.2%, respectively, while the SPY returned +3.6% and +4.7%, respectively.

WHWK support price is $3.95 and resistance is $4.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WHWK shares will trade within this expected range on the day.